Furthermore, TP53 R72 SNPs were detected in most HPV(+) HNSCC patients, with the exception of five patients, giving an 89% prevalence among the HPV(+) patients, which is a significantly higher preponderance of this particular SNP than among the HPV(−) patients. This evidence concerns the gene TP53 and head and neck squamous cell carcinoma.